BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 30523328)

  • 1. Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma.
    Ledergor G; Weiner A; Zada M; Wang SY; Cohen YC; Gatt ME; Snir N; Magen H; Koren-Michowitz M; Herzog-Tzarfati K; Keren-Shaul H; Bornstein C; Rotkopf R; Yofe I; David E; Yellapantula V; Kay S; Salai M; Ben Yehuda D; Nagler A; Shvidel L; Orr-Urtreger A; Halpern KB; Itzkovitz S; Landgren O; San-Miguel J; Paiva B; Keats JJ; Papaemmanuil E; Avivi I; Barbash GI; Tanay A; Amit I
    Nat Med; 2018 Dec; 24(12):1867-1876. PubMed ID: 30523328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoldering multiple myeloma: taking the narrow over the wide path?
    Avet-Loiseau H; Bahlis NJ
    Blood; 2024 May; 143(20):2025-2028. PubMed ID: 38427775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.
    Dang M; Wang R; Lee HC; Patel KK; Becnel MR; Han G; Thomas SK; Hao D; Chu Y; Weber DM; Lin P; Lutter-Berka Z; Berrios Nolasco DA; Huang M; Bansal H; Song X; Zhang J; Futreal A; Moreno Rueda LY; Symer DE; Green MR; Rojas Hernandez CM; Kroll M; Afshar-Khargan V; Ndacayisaba LJ; Kuhn P; Neelapu SS; Orlowski RZ; Wang L; Manasanch EE
    Cancer Cell; 2023 Jun; 41(6):1032-1047.e4. PubMed ID: 37311413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma.
    Merz M; Merz AMA; Wang J; Wei L; Hu Q; Hutson N; Rondeau C; Celotto K; Belal A; Alberico R; Block AW; Mohammadpour H; Wallace PK; Tario J; Luce J; Glenn ST; Singh P; Herr MM; Hahn T; Samur M; Munshi N; Liu S; McCarthy PL; Hillengass J
    Nat Commun; 2022 Feb; 13(1):807. PubMed ID: 35145077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.
    Croucher DC; Richards LM; Tsofack SP; Waller D; Li Z; Wei EN; Huang XF; Chesi M; Bergsagel PL; Sebag M; Pugh TJ; Trudel S
    Nat Commun; 2021 Nov; 12(1):6322. PubMed ID: 34732728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.
    John L; Poos AM; Brobeil A; Schinke C; Huhn S; Prokoph N; Lutz R; Wagner B; Zangari M; Tirier SM; Mallm JP; Schumacher S; Vonficht D; Solé-Boldo L; Quick S; Steiger S; Przybilla MJ; Bauer K; Baumann A; Hemmer S; Rehnitz C; Lückerath C; Sachpekidis C; Mechtersheimer G; Haberkorn U; Dimitrakopoulou-Strauss A; Reichert P; Barlogie B; Müller-Tidow C; Goldschmidt H; Hillengass J; Rasche L; Haas SF; van Rhee F; Rippe K; Raab MS; Sauer S; Weinhold N
    Nat Commun; 2023 Aug; 14(1):5011. PubMed ID: 37591845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular pathogenesis of multiple myeloma.
    Bolli N; Martinelli G; Cerchione C
    Hematol Rep; 2020 Dec; 12(3):9054. PubMed ID: 33408844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaxman I, Gertz MA. How I approach smoldering multiple myeloma. Blood. 2022;140(8):828-838.
    Blood; 2023 Mar; 141(11):1366. PubMed ID: 36929433
    [No Abstract]   [Full Text] [Related]  

  • 9. A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.
    Da Vià MC; Ziccheddu B; Maeda A; Bagnoli F; Perrone G; Bolli N
    Hemasphere; 2020 Dec; 4(6):e502. PubMed ID: 33283171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoid Modeling of the Tumor Immune Microenvironment.
    Neal JT; Li X; Zhu J; Giangarra V; Grzeskowiak CL; Ju J; Liu IH; Chiou SH; Salahudeen AA; Smith AR; Deutsch BC; Liao L; Zemek AJ; Zhao F; Karlsson K; Schultz LM; Metzner TJ; Nadauld LD; Tseng YY; Alkhairy S; Oh C; Keskula P; Mendoza-Villanueva D; De La Vega FM; Kunz PL; Liao JC; Leppert JT; Sunwoo JB; Sabatti C; Boehm JS; Hahn WC; Zheng GXY; Davis MM; Kuo CJ
    Cell; 2018 Dec; 175(7):1972-1988.e16. PubMed ID: 30550791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.
    Reyfman PA; Walter JM; Joshi N; Anekalla KR; McQuattie-Pimentel AC; Chiu S; Fernandez R; Akbarpour M; Chen CI; Ren Z; Verma R; Abdala-Valencia H; Nam K; Chi M; Han S; Gonzalez-Gonzalez FJ; Soberanes S; Watanabe S; Williams KJN; Flozak AS; Nicholson TT; Morgan VK; Winter DR; Hinchcliff M; Hrusch CL; Guzy RD; Bonham CA; Sperling AI; Bag R; Hamanaka RB; Mutlu GM; Yeldandi AV; Marshall SA; Shilatifard A; Amaral LAN; Perlman H; Sznajder JI; Argento AC; Gillespie CT; Dematte J; Jain M; Singer BD; Ridge KM; Lam AP; Bharat A; Bhorade SM; Gottardi CJ; Budinger GRS; Misharin AV
    Am J Respir Crit Care Med; 2019 Jun; 199(12):1517-1536. PubMed ID: 30554520
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular signatures of multiple myeloma progression through single cell RNA-Seq.
    Jang JS; Li Y; Mitra AK; Bi L; Abyzov A; van Wijnen AJ; Baughn LB; Van Ness B; Rajkumar V; Kumar S; Jen J
    Blood Cancer J; 2019 Jan; 9(1):2. PubMed ID: 30607001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
    Li H; van der Leun AM; Yofe I; Lubling Y; Gelbard-Solodkin D; van Akkooi ACJ; van den Braber M; Rozeman EA; Haanen JBAG; Blank CU; Horlings HM; David E; Baran Y; Bercovich A; Lifshitz A; Schumacher TN; Tanay A; Amit I
    Cell; 2019 Feb; 176(4):775-789.e18. PubMed ID: 30595452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
    Garris CS; Arlauckas SP; Kohler RH; Trefny MP; Garren S; Piot C; Engblom C; Pfirschke C; Siwicki M; Gungabeesoon J; Freeman GJ; Warren SE; Ong S; Browning E; Twitty CG; Pierce RH; Le MH; Algazi AP; Daud AI; Pai SI; Zippelius A; Weissleder R; Pittet MJ
    Immunity; 2018 Dec; 49(6):1148-1161.e7. PubMed ID: 30552023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
    Adams HC; Stevenaert F; Krejcik J; Van der Borght K; Smets T; Bald J; Abraham Y; Ceulemans H; Chiu C; Vanhoof G; Usmani SZ; Plesner T; Lonial S; Nijhof I; Lokhorst HM; Mutis T; van de Donk NWCJ; Sasser AK; Casneuf T
    Cytometry A; 2019 Mar; 95(3):279-289. PubMed ID: 30536810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.
    Rasche L; Alapat D; Kumar M; Gershner G; McDonald J; Wardell CP; Samant R; Van Hemert R; Epstein J; Williams AF; Thanendrarajan S; Schinke C; Bauer M; Ashby C; Tytarenko RG; van Rhee F; Walker BA; Zangari M; Barlogie B; Davies FE; Morgan GJ; Weinhold N
    Leukemia; 2019 Jul; 33(7):1713-1722. PubMed ID: 30573775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell Transcriptome Profiling of Mouse and hESC-Derived Pancreatic Progenitors.
    Krentz NAJ; Lee MYY; Xu EE; Sproul SLJ; Maslova A; Sasaki S; Lynn FC
    Stem Cell Reports; 2018 Dec; 11(6):1551-1564. PubMed ID: 30540962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
    Ryu D; Kim SJ; Hong Y; Jo A; Kim N; Kim HJ; Lee HO; Kim K; Park WY
    Clin Cancer Res; 2020 Feb; 26(4):935-944. PubMed ID: 31558476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli Are Altered with Age.
    Mann M; Mehta A; de Boer CG; Kowalczyk MS; Lee K; Haldeman P; Rogel N; Knecht AR; Farouq D; Regev A; Baltimore D
    Cell Rep; 2018 Dec; 25(11):2992-3005.e5. PubMed ID: 30540934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Dimopoulos MA; Gay F; Schjesvold F; Beksac M; Hajek R; Weisel KC; Goldschmidt H; Maisnar V; Moreau P; Min CK; Pluta A; Chng WJ; Kaiser M; Zweegman S; Mateos MV; Spencer A; Iida S; Morgan G; Suryanarayan K; Teng Z; Skacel T; Palumbo A; Dash AB; Gupta N; Labotka R; Rajkumar SV;
    Lancet; 2019 Jan; 393(10168):253-264. PubMed ID: 30545780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.